Normal vs Denervated Muscle: Why the Rules of Electrical Stimulation Change After Nerve Injury
It is quite common for us to meet clients who have tried electrical stimulation on a limb and found that nothing happened. No matter how high the intensity was set, the muscle simply would not contract. They arrive frustrated, sometimes having been told that nothing more can be done. When we then use the RISE Stimulator, a specialist device capable of producing the long-impulse-duration waveforms that denervated muscle actually requires, they are often surprised and relieved to see a contraction for the first time.
That moment of surprise reveals an important gap in understanding. The muscle did not fail to respond because it was beyond help. It failed because the wrong electrical 'language' was being spoken. A denervated muscle is not simply a weak muscle. It is, in a very real sense, a different tissue with altered structure, electrical properties, and activation rules. Understanding these differences is the foundation for making sense of any treatment approach.
This article establishes the scientific basis for that difference. We begin with how normal skeletal muscle works: the motor unit, the neuromuscular junction, and the elegant chain of events that converts a nerve impulse into a muscle contraction. We then examine what happens when the nerve supply is lost. We find a cascade of degenerative changes that transform functioning muscle into something quite different. Finally, we compare the two side by side, highlighting the key differences that determine how each tissue responds to electrical stimulation.
The goal is not to produce a textbook on muscle physiology. It is to give you, whether you are a physiotherapist, a rehabilitation specialist, a case manager, or someone living with a nerve injury, enough understanding of the biology to see why the rules change so dramatically after denervation. If you grasp the content of this article, the clinical decisions that follow will make intuitive sense.
Normal Skeletal Muscle — How It Works
The motor unit — the functional unit of movement
All voluntary movement begins with the motor unit. A motor unit consists of a single motor neuron with its cell body in the spinal cord, its axon extending through a peripheral nerve, and all the muscle fibres it innervates. When the motor neuron 'fires', every fibre in that unit contracts simultaneously. This is the fundamental building block of movement.
Motor unit size varies enormously depending on the precision required by that body part. In the extraocular muscles that control eye movement, a single motor neuron may innervate only five to ten muscle fibres, allowing exquisitely fine control. In the quadriceps, the large thigh muscles, perhaps most relevant to spinal cord injury rehabilitation, one motor neuron may serve a thousand or more fibres. The trade-off is straightforward: small motor units allow precision, large motor units produce force.
When voluntary movement is needed, motor units are recruited in an orderly sequence. This is known as Henneman's size principle, established in 1965, and it remains one of the most reliable rules in motor physiology. Small motor units, which tend to contain slow, fatigue-resistant fibres, are recruited first. As more force is required, larger motor units containing faster, more powerful fibres are progressively added. This graded recruitment allows the nervous system to produce everything from the delicate grip needed to hold a pen to the explosive force required for a standing transfer.
In normal muscle, the nervous system manages recruitment with remarkable precision and this is lost when the nerve supply is interrupted.
Muscle fibre types — the mixed mosaic
Not all muscle fibres are the same. Human skeletal muscle contains a mixture of fibre types, broadly classified into three categories.
Type I (slow oxidative) fibres are designed for endurance. They contract relatively slowly, resist fatigue, and rely on aerobic metabolism. These are the fibres that maintain posture and sustain low-intensity activity over long periods. They appear red under the microscope because of their rich blood supply and high myoglobin content.
Type IIa (fast oxidative-glycolytic) fibres represent an intermediate type. They can produce moderate force with reasonable fatigue resistance, drawing on both aerobic and anaerobic pathways.
Type IIx (fast glycolytic) fibres are built for power. They contract quickly and forcefully but fatigue rapidly, relying primarily on anaerobic glycolysis. They appear pale, white muscle, in everyday terms.
In healthy, innervated muscle, these fibre types are distributed in a mixed pattern we could describe as a mosaic. If you were to stain a cross-section of normal muscle using the ATPase technique and view it under a microscope, you would see a pattern resembling a chessboard: light and dark fibres interleaved, with no large clusters of a single type. Each motor unit consists of a single fibre type, but the units themselves are scattered, producing the characteristic mixed appearance.
This distribution matters because it gives the muscle versatility. A healthy quadriceps can sustain posture, absorb shock during walking, and produce rapid force during a stumble recovery, all because the mix of fibre types is maintained by normal neural activity. When denervation disrupts this, the consequences for muscle function are profound.
The neuromuscular junction — the 'relay station'
For a nerve impulse to produce a muscle contraction, the electrical signal must somehow cross from nerve to muscle. This occurs at the neuromuscular junction (NMJ), a highly specialised synapse between the motor neuron terminal and the muscle fibre membrane.
The NMJ has three components. The presynaptic terminal is the swollen end of the motor neuron's axon, packed with vesicles containing the neurotransmitter acetylcholine (ACh). The synaptic cleft is a narrow gap of approximately 50 nanometres wide between nerve and muscle. The postsynaptic membrane is a folded region of the muscle fibre surface (the end-plate), densely populated with ACh receptors concentrated at the crests of the folds.
When an action potential arrives at the nerve terminal, it triggers the release of ACh into the synaptic cleft. ACh molecules bind to receptors on the muscle fibre membrane, generating a localised electrical signal called the end-plate potential. If large enough, this triggers a full action potential in the muscle fibre. This action potential then propagates along the fibre's surface, initiating contraction.
The NMJ is a remarkably reliable signal amplifier. Under normal conditions, every nerve impulse produces a muscle fibre action potential. A large safety factor is built into the system. Think of it as a relay station between the nervous system and the muscle: the nerve sends its command, the NMJ translates it faithfully, and the muscle responds.
This reliability is a crucial context for understanding denervation. When the NMJ is destroyed, as it is when the nerve supply is lost, that relay station is gone. The muscle fibre is no longer connected to the nervous system. **To activate it, you must depolarise the muscle fibre membrane directly, and this requires a fundamentally different electrical approach.**
Excitation-contraction coupling — from electrical signal to mechanical force
Once the action potential propagates along the muscle fibre's surface membrane (the sarcolemma), it must be translated into mechanical force. This process of excitation-contraction coupling is an elegant chain of events that happens in milliseconds.
The action potential travels not only along the fibre's surface but also deep into its interior through a network of narrow tubes called transverse tubules, or T-tubules. These T-tubules penetrate the fibre at regular intervals and form junctions, so-called triads, with the sarcoplasmic reticulum (SR), an internal membrane system that stores calcium ions.
When the T-tubule depolarises, it triggers the release of calcium from the SR into the surrounding cytoplasm. This calcium binds to a regulatory protein called troponin, which is associated with the thin filaments of the contractile machinery. Calcium binding causes a shape change that exposes binding sites on actin, allowing the thick filaments (myosin) to attach and pull. This is the sliding filament mechanism, first described by Huxley and Niedergerke in 1954, and it remains the accepted model of muscle contraction.
Relaxation occurs when calcium is actively pumped back into the SR, troponin returns to its resting configuration, and the cross-bridges disengage. The whole cycle of activation, contraction, and relaxation can repeat rapidly, producing the sustained, graded force we recognise as functional movement.
The clinical relevance of this sequence is twofold. First, when the nerve is intact, a tiny external electrical pulse, less than 1 millisecond in duration and at a modest current, can trigger this entire cascade by activating the nerve. The nerve then does the rest: firing the NMJ, propagating the action potential, and engaging the calcium-release system. This is the basis of neuromuscular electrical stimulation (NMES), and it is why NMES works so well on innervated muscle.
Secondly, and this is the critical point, when the nerve is lost, this cascade breaks down at multiple levels. Not just at the NMJ, but in the T-tubule system, the calcium stores, and eventually the contractile proteins themselves. The tissue does not merely lose its controller. Over time, it loses the internal machinery that enables contraction.
With this understanding of how normal muscle works, we can turn to what happens when the nerve is lost.
What Happens When the Nerve Is Lost. The Denervation Cascade
Before examining the specific changes that follow denervation, it is worth pausing on a fundamental point. **The motor neuron does more than transmit electrical impulses for contraction. It provides a continuous *neurotrophic* influence**. This is a steady stream of chemical signals that maintain the muscle fibre's specialised biochemical environment and structural integrity. Growth factors, signalling molecules, and the specific pattern of neural activity all contribute to keeping the muscle in its differentiated, functional state. When this trophic support is withdrawn, denervation becomes not merely a loss of voluntary control but a failure of the entire regulatory system that sustains muscle tissue. This is why the consequences are so far-reaching and why they extend well beyond simple disuse atrophy.
Causes of denervation
Muscle can lose its nerve supply through several mechanisms, but two causes dominate and they differ fundamentally in their implications for recovery.
The first is peripheral nerve injury resulting from trauma, compression, or surgical damage. Here, the motor neuron cell body in the spinal cord typically survives; only the axon is disrupted along its course. Because the cell body is intact, regeneration is biologically possible, and the question becomes whether the regenerating nerve can reach the muscle before irreversible deterioration occurs.
The second is a spinal cord injury affecting lower motor neurons. When the injury is at the level of the conus medullaris (the terminal portion of the spinal cord, roughly at the T12–L1 vertebral level) or the cauda equina (the nerve roots below), the motor neuron cell bodies or their nerve roots are damaged or destroyed directly. There is no intact cell body from which regeneration can begin, and the denervation is permanent. Many spinal cord injuries produce a mixture of both upper motor neuron damage above the lesion level and lower motor neuron damage at the level of the lesion itself. Distinguishing between the two is essential for selecting the right stimulation approach.
Other causes include neuromuscular diseases such as amyotrophic lateral sclerosis (ALS), Guillain-Barré syndrome, and the late effects of poliomyelitis. Diabetes, radiation therapy, and certain surgical procedures can also cause denervation of individual muscles or muscle groups.
The key distinction is this: in some injuries, the nerve can regenerate and eventually reinnervate the muscle. In other cases, particularly where the nerve cell body itself is destroyed, reinnervation will not occur, and the denervation is permanent. Permanent denervation poses the greatest challenge and is frequently the focus of our work with the RISE Stimulator.
Wallerian degeneration — the nerve highway is dismantled
When the axon is disrupted, the portion distal to the injury degenerates through a process known as Wallerian degeneration. Far from passive decay, this is an actively programmed process. Think of it as a 'controlled demolition' driven by specific molecular machinery that dismantles the nerve connection over the course of weeks. The essential point is that once Wallerian degeneration runs its course, the muscle is 'on its own'.
The neuromuscular junction disassembles
Without ongoing nerve terminal activity, the neuromuscular junction begins to degrade. The precisely organised postsynaptic structure, consisting of tightly packed ACh receptor clusters at the end-plate, disperses. ACh receptors, normally concentrated at the NMJ, spread across the entire surface of the muscle fibre membrane, a phenomenon known as denervation supersensitivity. The fibre becomes sensitive to acetylcholine along its whole length, but paradoxically, there is no longer any nerve terminal to release it.
The loss of the NMJ means the muscle fibre has lost its normal route of activation. The relay station is gone. Any electrical signal that aims to produce a contraction must now depolarise the muscle fibre membrane directly, which is a fundamentally different and much more demanding task than activating the nerve.
Changes in the muscle fibre itself
The consequences of denervation for the muscle fibre unfold over a broadly predictable timeline, though the exact pace varies between individuals and between muscles.
Early changes (weeks to months).
Within days of denervation, the fibre begins to exhibit spontaneous electrical activity known as fibrillation potentials. These are small, uncoordinated twitches invisible to the naked eye but detectable on electromyography (EMG). At the molecular level, muscle protein synthesis declines, and the ubiquitin-proteasome degradation pathway becomes active. Two muscle-specific ubiquitin ligases, MuRF1 and MAFbx (also called atrogin-1) are rapidly upregulated, as Bodine and colleagues demonstrated in their landmark 2001 study. These molecular "switches" drive the targeted breakdown of contractile proteins. Muscle fibres begin to shrink. In this early phase, the muscle still retains much of its structural organisation, but it is already losing mass.
Intermediate changes (months to one to two years).
The atrophy becomes visible and measurable. The cross-sectional area of individual fibres can decline by 30 to 50 per cent within the first year. The fibre-type composition begins to shift. Without neural activity to maintain the normal mix, fibres progressively convert to the fast glycolytic (Type IIx) phenotype. The muscle's endurance characteristics are lost.
Perhaps most critically for the possibility of electrical stimulation, the T-tubule and triad system, representing the internal architecture that couples the electrical signal to calcium release, becomes progressively disorganised. This was documented clearly by Kern and colleagues in 2004, who showed through muscle biopsies that long-term denervation destroys not only the contractile proteins but also the excitation-contraction coupling apparatus itself. Specifically, the Ryanodine Receptors (RyRs), the calcium-release channels that span the gap between T-tubule and sarcoplasmic reticulum, are progressively lost. Without these receptors, the triad junction may remain structurally intact but be functionally incapable of the calcium release required for contraction.
Late changes (two to six years and beyond).
With prolonged denervation, the muscle undergoes fibro-fatty degeneration. Muscle fibres are progressively replaced by collagen and adipose tissue. In long-term denervated degenerated muscle, biopsy studies have found connective tissue occupying over 60 per cent of the tissue area, with fat accounting for a further 12–13 per cent. The remaining fibres become severely atrophic, with mean diameters dropping below 20 micrometres compared to the 50–80 micrometres typical of healthy muscle.
A denervated muscle at this stage feels different to the touch. Where healthy quadriceps muscle is firm and resilient, a long-denervated thigh feels soft and doughy, noticeably reduced in girth. Clients often notice this change themselves because the cosmetic appearance of wasted thighs is striking, and many remark on it before any clinician explains the underlying science.
Eventually, if unchecked, the tissue reaches a point at which contraction is no longer possible, regardless of the stimulation applied. The contractile machinery is too degraded, the fibre population too sparse.
But not all is lost. Satellite cells may persist
Against this backdrop of progressive degeneration, one finding offers genuine grounds for optimism. Satellite cells, which are the resident stem cells of skeletal muscle, and normally sit quiescent between the fibre membrane and its surrounding basal lamina, can persist in denervated muscle.
Kern's biopsy studies demonstrated something remarkable: even in muscle that had been denervated for three years or more, researchers found that between 1 and 9 per cent of fibres expressed embryonic myosin heavy chain (MHCemb). This is a protein normally seen only in newly forming muscle fibres during development or regeneration. Because MHCemb is only transiently expressed, these fibres must have been generated within weeks of the biopsy being taken. This is direct evidence that satellite cells are not simply surviving but are actively generating new muscle fibres, even years after the nerve supply was lost.
This regenerative activity diminishes over time, and without reinnervation or external stimulation, newly formed fibres undergo the same cycle of atrophy and eventually fail to reach functional maturity. The muscle continually attempts repair but cannot sustain it. Yet the biological machinery for recovery is present, waiting to be supported. This is one of the key reasons why electrical stimulation of denervated muscle can produce meaningful results. It works with an ongoing, if diminishing, regenerative process which always better than trying to restart one from nothing.
Chronaxie — the diagnostic fingerprint
Of all the differences listed above, the change in electrical excitability is perhaps the most clinically significant. It can be relatively easily measured, it predicts whether standard stimulation will work, and it guides the selection of appropriate parameters.
*Chronaxie* is a measure of how quickly a tissue responds to an electrical pulse. In normal, innervated muscle, chronaxie is typically less than 1 millisecond. A short, sharp pulse easily triggers an action potential in the nerve, which then activates the entire contraction cascade. In denervated muscle, chronaxie shifts to more than 20 milliseconds, and in severe cases may exceed 100 milliseconds — a shift of one hundred-fold or more.
Standard NMES devices deliver pulses of 200 to 400 microseconds — far too brief to reach this threshold. This is why NMES fails in denervated muscle. The pulse is the wrong shape, regardless of how strong it is. You can read more about this in our article [Why your NMES product probably doesn't work with denervated muscle](https://www.anatomicalconcepts.com/articles/why-your-nmes-product-probably-doesnt-work-with-denervated-muscle).
Why This Matters for Treatment
Understanding the differences described in this article leads to a clear conclusion: a denervated muscle is not unreachable, but you must speak its 'electrical language.'
Every aspect of the stimulation approach must change — pulse duration, current intensity, frequency, and electrode configuration. These are not arbitrary adjustments. Everything follows logically from the tissue changes described above:
The shifted chronaxie demands longer pulses - 40 to 200 milliseconds, compared to less than 1 millisecond for innervated muscle
The absence of nerve amplification demands higher currents— up to 250 milliamps, compared to less than 130 milliamps for standard NMES
The slower contraction dynamics demand lower frequencies— 1 to 20 Hz, compared to 20 to 50 Hz for innervated muscle
The lack of motor points demands larger electrodes — covering the whole muscle, because there is no single point where the nerve enters and branches and we rely on direct contraction of muscle fibre.
The window of opportunity
The timeline of denervation described above carries an important practical message: degeneration is progressive but not instantaneous. There is a window of opportunity, particularly in the first one to two years after denervation, when muscle fibres remain structurally intact enough to respond to direct electrical stimulation and satellite cell activity remains robust enough to support regeneration.
The evidence from Kern and colleagues is instructive. Their landmark study demonstrated that home-based functional electrical stimulation produced measurable improvements even in patients who had been denervated for up to nine years, with biopsy-confirmed structural restoration of muscle tissue. The restored bulk of tissue was not merely cosmetic swelling. The best outcomes, though, were consistently seen in those who started treatment earlier.
In our experience, clients who begin a stimulation programme within the first year tend to achieve faster, more pronounced gains in muscle bulk and function. Some who were initially assessed as having incomplete denervation have, over time, progressed from denervated-muscle stimulation protocols to those more suggestive of innervated muscle. Others with genuinely permanent denervation have still achieved meaningful improvements in muscle girth, tissue health, and limb appearance, greatly improving their quality of life. Gains of three to five centimetres in thigh circumference within six months are not uncommon, and for many clients, this visible change is the first tangible evidence that progress is possible.
The critical point is this: early intervention produces better outcomes, but it is rarely too late to begin. The biological machinery — satellite cells, surviving muscle fibres, and the capacity for structural remodelling — persists longer than earlier clinical dogma suggested.
Key Takeaways
Normal muscle is an elegantly organised tissue that responds to tiny electrical inputs via the nerve
Denervation triggers a cascade of degenerative changes: NMJ breakdown, contractile degradation, calcium system failure, and ultimately fibro-fatty replacement
This degeneration follows a predictable timeline, but early intervention can interrupt it
A denervated muscle has fundamentally different electrical properties, with chronaxie shifting one hundred-fold
Standard NMES cannot activate a denervated muscle; purpose-built stimulation, such as with the RISE Stimulator, is required
Satellite cells persist, offering a biological basis for recovery if stimulation begins in time
Science is the foundation. What matters is what you do with it.
What to Do Next
If you or someone you work with is living with denervated muscle, whether from spinal cord injury, peripheral nerve damage, or another cause, the first step is understanding the tissue. This article has given you that foundation.
The next step is a proper assessment. At Anatomical Concepts, we can use impulse testing to map the strength-duration curve and determine the exact stimulation parameters each individual needs. The RISE Stimulator features a built-in impulse testing function that allows this to be done at the bedside or in the home.
If you would like to learn more, contact us. for an initial conversation. We are happy to discuss your specific situation and advise on whether electrical stimulation for denervated muscle is appropriate.
This article is a modified version of Chapter One of our comprehensive book on Electrical Stimulation of Denervated Muscle, which is available on our website denervatedmuscle.com
Research Literature
Bodine, S.C., et al. (2001), 'Identification of ubiquitin ligases required for skeletal muscle atrophy', *Science*, 294 (5547), 1704–08.
Kern, H., et al. (2004), 'Long-term denervation in humans causes degeneration of both contractile and excitation-contraction coupling apparatus, which is reversible by functional electrical stimulation (FES): a role for myofiber regeneration', *J Neuropathol Exp Neurol*, 63 (9), 919–31.
Kern, H., et al. (2005), 'Muscle biopsies show that FES of denervated muscles reverses human muscle degeneration from permanent spinal motoneuron lesion', *J Rehabil Res Dev*, 42 (3 Suppl 1), 43–53.
Kern, H., et al. (2010), 'Home-Based Functional Electrical Stimulation Rescues Permanently Denervated Muscles in Paraplegic Patients With Complete Lower Motor Neuron Lesion', *Neurorehabil Neural Repair*, 24 (8), 709–21.
Kern, H. and Carraro, U. (2020), 'Home-Based Functional Electrical Stimulation of Human Permanent Denervated Muscles: A Narrative Review on Diagnostics, Managements, Results and Byproducts Revisited 2020', *Diagnostics (Basel)*, 10 (8), 529.
Sandri, M., et al. (2004), 'Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy', *Cell*, 117 (3), 399–412.
Related Articles
- Can you stimulate a denervated muscle (https://www.anatomicalconcepts.com/articles/can-you-stimulate-a-denervated-muscle)
- Why your NMES product probably doesn't work with denervated muscle (https://www.anatomicalconcepts.com/articles/why-your-nmes-product-probably-doesnt-work-with-denervated-muscle)
- Can electrical stimulation help denervated muscles recover? (https://www.anatomicalconcepts.com/articles/can-electrical-stimulation-help-denervated-muscles-recover)
- Denervated muscle stimulation: why optimal intensity beats maximum intensity(https://www.anatomicalconcepts.com/articles/denervated-muscle-stimulation-why-optimal-intensity-beats-maximum-intensity)